| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/28/2000 | CA2368229A1 50 human secreted proteins |
| 09/28/2000 | CA2368223A1 48 human secreted proteins |
| 09/28/2000 | CA2368210A1 50 human secreted proteins |
| 09/28/2000 | CA2367736A1 Surface and its manufacture and uses |
| 09/28/2000 | CA2367620A1 47 human secreted proteins |
| 09/28/2000 | CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites |
| 09/28/2000 | CA2367476A1 Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture |
| 09/28/2000 | CA2367464A1 Materials and methods relating to modulation of p66 expression |
| 09/28/2000 | CA2367125A1 Reagents and methods useful for detecting diseases of the prostate |
| 09/28/2000 | CA2366691A1 48 human secreted proteins |
| 09/28/2000 | CA2366669A1 Cell-culture and polymer constructs |
| 09/28/2000 | CA2366267A1 49 human secreted proteins |
| 09/28/2000 | CA2366228A1 Chimeric promoters based on the plastocyanin pete promoter from pea |
| 09/28/2000 | CA2366214A1 Dsp-2 dual-specificity map kinase phosphatase |
| 09/28/2000 | CA2366132A1 48 human secreted proteins |
| 09/28/2000 | CA2365255A1 Human tumor necrosis factor receptor tr9 |
| 09/28/2000 | CA2365247A1 49 human secreted proteins |
| 09/28/2000 | CA2365243A1 Human transmembrane proteins |
| 09/28/2000 | CA2365238A1 48 human secreted proteins |
| 09/28/2000 | CA2365223A1 46 human secreted proteins |
| 09/28/2000 | CA2365104A1 Anti-p53 antibodies |
| 09/28/2000 | CA2364607A1 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same |
| 09/28/2000 | CA2361221A1 Novel protein which induces chondrocyte differentiation |
| 09/27/2000 | EP1038963A2 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
| 09/27/2000 | EP1038959A1 Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX |
| 09/27/2000 | EP1038957A1 Tsa305 gene |
| 09/27/2000 | EP1038952A2 Processes for preparation of Marek's Disease Virus using continuous avian cell lines |
| 09/27/2000 | EP1038020A1 Secreted protein nsl4 |
| 09/27/2000 | EP1038017A2 The use of consensus sequences for targeted homologous gene isolation and recombination in gene families |
| 09/27/2000 | EP1038015A2 Mood disorder gene |
| 09/27/2000 | EP1038014A1 VEGETABLE (GntI) SEQUENCES AND THE USE THEREOF TO OBTAIN PLANTS WITH A REDUCED OR LACK OF N-ACETYLGLUCOSAMINYLTRANSFERASE I (GnTI) ACTIVITY |
| 09/27/2000 | EP1038012A2 Method for producing transgenic plants with modified 5-aminolevulinic acid biosynthesis, method for identifying 5-aminolevulinic acid synthesis effectors |
| 09/27/2000 | EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 09/27/2000 | EP1038008A2 Egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes |
| 09/27/2000 | EP1038003A1 Cyclic gmp phosphodiesterase |
| 09/27/2000 | EP1038002A1 Ubiquitin-like conjugating protein |
| 09/27/2000 | EP1038000A1 Compounds and methods for the detection and prevention of (t. cruzi) infection |
| 09/27/2000 | EP1037999A1 Porphorymonas gingivalis polypeptides and nucleotides |
| 09/27/2000 | EP1037998A1 guaA POLYPEPTIDES |
| 09/27/2000 | EP1037995A1 Human interferon-epsilon: a type 1 interferon |
| 09/27/2000 | EP1037993A2 A new gene called oligophrenin 1, its expression product, and the diagnostic and therapeutic applications thereof |
| 09/27/2000 | EP1037992A1 P53 regulatory protein called rb18a and uses thereof |
| 09/27/2000 | EP1037991A1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| 09/27/2000 | EP1037990A1 Human sel-10 polypeptides and polynucleotides that encode them |
| 09/27/2000 | EP1037987A2 14-3-3$g(s) ARRESTS THE CELL CYCLE |
| 09/27/2000 | EP1037985A1 Restin and methods of use thereof |
| 09/27/2000 | EP1037984A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 09/27/2000 | EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 09/27/2000 | EP1037981A1 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/27/2000 | EP1037980A1 G-protein coupled receptors associated with immune response |
| 09/27/2000 | EP1037979A2 Polypeptides and nucleic acids encoding the same |
| 09/27/2000 | EP1037978A1 Human rad1 nucleic acid, polypeptides, assays, therapeutic methods and means |
| 09/27/2000 | EP1037977A2 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 09/27/2000 | EP1037974A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
| 09/27/2000 | EP1037970A1 Secreted proteins and polynucleotides encoding them |
| 09/27/2000 | EP1037967A2 Human phosphatases |
| 09/27/2000 | EP1037966A1 Industrial production of meat from in vitro cell cultures |
| 09/27/2000 | EP1037965A1 Methods for preparation of vaccines against cancer |
| 09/27/2000 | EP1037924A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna |
| 09/27/2000 | EP1037922A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 09/27/2000 | EP1037921A1 Erythropoietin with high specific activity |
| 09/27/2000 | EP1037917A1 Recombinant nodavirus compositions and methods |
| 09/27/2000 | EP1037915A1 Matrix-remodeling genes |
| 09/27/2000 | EP1037913A1 Galanin receptor galr3 and nucleotides encoding same |
| 09/27/2000 | EP1037912A1 DNA MOLECULES ENCODING VERTEBRATE NUCLEAR RECEPTOR PROTEIN, nNR4 |
| 09/27/2000 | EP1037909A2 Postweaning multisystemic wasting syndrome virus from pigs |
| 09/27/2000 | EP1037908A2 Human tumor necrosis factor-r2-like proteins |
| 09/27/2000 | EP1037907A2 Bone morphogenetic protein (bmp) -17 and bmp-18 and compositions thereof |
| 09/27/2000 | EP1037900A1 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 09/27/2000 | EP1037899A1 Secreted proteins and polynucleotides encoding them |
| 09/27/2000 | EP1037661A1 ribH |
| 09/27/2000 | EP1037660A1 ribB |
| 09/27/2000 | EP1037658A1 Ifnar2/ifn complex |
| 09/27/2000 | EP1037654A1 ribA |
| 09/27/2000 | EP1037643A1 Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy |
| 09/27/2000 | EP1037603A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 09/27/2000 | EP1037530A1 ribG |
| 09/27/2000 | EP1037523A1 Genetically engineered duckweed |
| 09/27/2000 | EP0805819A4 Chimeric dna-binding proteins |
| 09/27/2000 | EP0778890B1 Dna encoding a human calcium channel alpha-1e subunit |
| 09/27/2000 | EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 09/27/2000 | CN1268184A Improved i (agrobacterium)-mediated transformation of plants |
| 09/27/2000 | CN1268183A Male tissue-perferred regulatory region and method of using same |
| 09/27/2000 | CN1268182A RANK1, an ankyrin-repeat containing peptide from rice associated with disease resistance |
| 09/27/2000 | CN1268180A Broad-spectrum delta-endotoxins |
| 09/27/2000 | CN1268177A Novel nucleic acid molecules and uses therefor |
| 09/27/2000 | CN1268175A Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 09/27/2000 | CN1268141A Recombinant expression of insulin C-peptide |
| 09/27/2000 | CN1267725A Hepatitis B virus nucleus and fore S1 area gene transfected mouse cell line (P99-815) and its preparation |
| 09/27/2000 | CN1267723A Saffron polyploid cell culture process to produce crosin and similar active matter |
| 09/27/2000 | CN1056880C Synthetic insecticidal crystal protein gene |
| 09/27/2000 | CN1056878C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 09/26/2000 | US6124446 Polynucleotide sequence coding a vacuolar separation polypeptide; for the diagnosis, treatment, and prevention of cancer, inflammatory, lysosomal storage and membrane transport defects; anticarciongenic agents |
| 09/26/2000 | US6124442 Obtaining a liquid extract from a fresh plant source material and mixing the extract with a solution saturated with at least one element having an oxidation number of one or two or combinations thereof |
| 09/26/2000 | US6124430 Amino acid squences useful as a reagent in an immunoassay for measuring and detection of heart hormone protein |
| 09/26/2000 | US6124265 Method of making and cross-linking keratin-based films and sheets |
| 09/26/2000 | US6124131 Protein associated with incresed oxygen demand; for treatment and prevention of tissues damage caused by lack of oxygen |
| 09/26/2000 | US6124128 Nucleic acid coding green fluorescent protein; for use as marker of gene expression, tracers of cell lineage and as fusion tags to monitor protein localization within viable cells |
| 09/26/2000 | US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides |
| 09/26/2000 | US6124115 Production and use of isolated type 5 17β-hydroxysteroid dehydrogenase |